Sabag Mark bought TEVA
December 9, 2025 · Form 4 insider transaction
Sabag Mark bought 118,724 shares of Teva Pharmaceutical Industries Limited at $18.61 per share, a transaction worth $2.21M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
118,724
Price
$18.61
Total value
$2.21M
InsiderSabag Mark
RoleOfficer
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateDecember 9, 2025
Filing dateDecember 11, 2025
Shares owned after269,720
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.